# Study Cyclosporine (CsA) Versus Tacrolimus (Tacro) After Campath Induction in Kidney Transplantation

> **NCT01346397** · — · COMPLETED · sponsor: **Russian Academy of Medical Sciences** · enrollment: 170 (actual)

## Conditions studied

- Acute Graft Rejection
- Chronic Allograft Nephropathy
- Polyomavirus-related Transplant Nephropathy

## Interventions

- **DRUG:** cyclosporine or tacrolimus

## Key facts

- **NCT ID:** NCT01346397
- **Lead sponsor:** Russian Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2013-05
- **Final completion:** 2016-05
- **Target enrollment:** 170 (ACTUAL)
- **Last updated:** 2016-11-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01346397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01346397, "Study Cyclosporine (CsA) Versus Tacrolimus (Tacro) After Campath Induction in Kidney Transplantation". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01346397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*